| http://www.w3.org/ns/prov#value | - Given that Xarelto is a Factor Xa inhibitor, also, this advancement by Portola with its new Xa antidote shoud benefit Boehringer Ingelheim, which has been the subject of recent lawsuits concerning serious bleeding events, some of which have been fatal.
|
